OSR Health, Inc. OSRH
0.23
(0.03)
(11.54%)
as of 25 Sep
- Market cap
- $4.1M
- P/E
- 0.0×
Follow OSRH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(22.63%) | (20.03%) | (14.32%) | (14.98%) | |
| (16.39%) | (15.62%) | (10.73%) | (11.24%) | ||
ROIC |
(6.22%) | (8.84%) | (9.12%) | (8.19%) | |
Return on Tangible Assets |
123.85% | 190.83% | 125.48% | 155.41% | |
Average Days of Receivables |
56.65 | 49.25 | 44.39 | 49.26 | |
Free Cash Flow per Share |
(0.16) | (0.24) | (0.17) | (0.22) | |
Free Cash Flow |
(3.44) | (4.76) | (5.27) | (7.20) | |
Capital Expenditures |
0.00 | (0.43) | — | — | |
Piotroski F-Score |
1.00 | 1.00 | 3.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(2.44%) | (3.25%) | (3.93%) | (5.46%) | |
Accounts Receivable Turnover |
0.00 | 4.38 | 4.70 | 3.63 | |
Accounts Payable Turnover |
0.63 | 0.52 | 0.26 | 0.15 | |
Inventory Turnover |
0.00 | 4.14 | 3.41 | 2.95 | |
Average Days of Payables |
993.14 | 1,235.67 | 1,475.39 | 2,496.34 | |
Days of Inventory on Hand |
23.99 | 30.99 | 82.59 | 185.32 | |
Tax Rate |
(0.12) | (0.08) | (0.13) | (0.15) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
412.43% | 651.42% | 748.30% | 969.01% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.24 | 0.16 | 0.28 | 0.36 | |
Depreciation/Fixed assets |
83.23 | 55.03 | 61.62 | 66.55 | |
Capex/Depreciation |
0.00 | (0.05) | 0.00 | 0.00 | |
Revenue per Share |
0.16 | 0.15 | 0.08 | 0.06 | |
Operating CF per Share |
(0.16) | (0.22) | (0.17) | (0.22) | |
Capex per Share |
0.00 | (0.02) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.15 | 0.00 | 0.00 | |
Net Profit Margin |
(422.34%) | (931.19%) | (707.50%) | (1,093.41%) |
Columns are period end dates